Article Sidebar
Published:
Jan 9, 2015Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Genoprotective and Genotoxic Effects of Thymoquinone on Doxorubicin-Induced Damage in Isolated Human Leukocytes
Abstract
Purpose: To investigate the potential genoprotective effects of thymoquinone (TQ) on the cytotoxicity and genotoxicity-induced by doxorubicin (DXR), a key chemotherapeutic drug.
Methods: Isolated human peripheral leukocytes were treated with varying concentrations of TQ (5.0, 10.0, or 20.0 µM) alone or in combination with DXR (0.15 ìg/mL). Comet assays and apoptotic cell studies were performed to evaluate the effect of TQ on the cytotoxicity and genotoxicity-induced by DXR.
Results: TQ treatment, alone, (5.0, 10, or 20 µM) increased DNA damage index (DI) in a concentrationdependent manner (0.64 ± 0.09, 0.84 ± 0.07, and 0.93 ± 0.06, respectively). DXR (0.15 µg/mL) increased DI (1.67 ± 0.09) compared with no treatment (0.34 ± 0.03). However, when TQ was administered with DXR, DI was significantly reduced (0.96 ± 0.04, 0.80 ± 0.05, and 0.79 ± 0.04) compared with DXR alone (1.67 ± 0.09). Similarly, apoptotic cells decreased (10.8, 11.8 and 14.2 %) compared with that induced by DXR alone (27.6 %).
Conclusion: TQ can be used as a genoprotective agent against DXR-induced genotoxicity. The dual behavior of TQ observed in this study is dose-dependent and therefore its mechanism of action needs to be clarified in future studies.
Keywords: Thymoquinone, Genotoxicity, Genoprotection, Doxorubicin, Apoptotic, Oxidative stress, DNA damage index
